Invasive fungal infections following liver transplantation - risk factors, incidence and outcome

Annals of Transplantation

Volumn 16, Issue 3, 2011, Pages 14-16

  Pacholczyk, Marek J ^a   Lagiewska, Beata ^a   Lisik, Wojciech ^a   Wasiak, Dariusz ^a   Chmura, Andrzej ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Aspergillosis; Fungal infection; Immunosuppression; Liver transplantation

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; METHYLPREDNISOLONE; VORICONAZOLE;

ACUTE GRAFT REJECTION; ARTICLE; ASPERGILLUS; AUTOIMMUNE DISEASE; BILE DUCT DISEASE; BILE DUCT NECROSIS; CANDIDA; CHOLESTASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS; CRYPTOCOCCUS ENCEPHALITIS; EARLY DIAGNOSIS; ENCEPHALITIS; GRAFT RECIPIENT; HUMAN; INCIDENCE; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; NECROSIS; PNEUMONIA; POSTOPERATIVE INFECTION; PULMONARY CANDIDIASIS; REOPERATION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SURVIVAL; SYSTEMIC MYCOSIS; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 80054859371     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.881989     Document Type: Article

References (14)

1. Brizendine KD, Vishin S, Baddley JW: Antifungal prophylaxis in solid organ transplant recipients. Expert Rev Anti Infect Ther, 2011, 9(5): 571-81
2. Neofytos D, Fishman JA, Horn D et al: Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis, 2010; 12(3): 220-29
3. Eschenauer GA, Lam SW, Carver PL: Antifungal prophylaxis in liver transplant recipients. Liver Transpl, 2009; 15(8): 842-58
4. Lease ED, Zaas DW: Update on infectious complications following lung transplantation. Curr Opin Pulm Med, 2011; 17(3): 206-9
5. Vadnerkar A, Clancy CJ, Celik U et al: Impact of mold infections in explanted lungs on outcomes of lung transplantation. Transplantation, 2010; 89(2): 253-60
6. Winkler M, Pratschke J, Schulz U et al: Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study. Transpl Infect Dis, 2010; 12(3): 230-37
7. Singh N: Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am, 2003; 17(1): 113-34
8. Silveira FP, Husain S: Fungal infections in solid organ transplantation. Med Mycol, 2007; 45(4): 305-20
9. Pagano L, Akova M, Dimopoulos G et al: Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother, 2011; 66(Suppl.1): i5-14
10. Feltracco P, Barbieri S, Furnari M et al: Central nervous system infectious complications early after liver transplantation. Transplant Proc, 2010; 42(4): 1216-22
11. Gangneux JP, Camus C, Philippe B: Epidemiology of invasive aspergillosis and risk factors in non neutropaenic patients. Rev Mal Respir, 2010; 27(8): e34-46
12. Alexander J, Limaye AP, Ko CW et al: Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. Liver Transpl, 2006; 12(12): 1799-804
13. Chang FY, Singh N, Gayowski T et al: Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation, 2000; 69(1): 70-75
14. Rodland EK, Ueland T, Pedersen TM et al: Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis. Infect Immun, 2010; 78(3): 1269-75